Melatonin modulates apomorphine-induced rotational behaviour.
Burton
S
S
School of Pharmaceutical Sciences, Rhodes University, Grahamstown, South Africa.
Daya
S
S
Potgieter
B
B
D000818:Animals; D001058:Apomorphine / Q000378:metabolism*; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D006816:Huntington Disease / Q000139:chemically induced; D006892:Hydroxydopamines; D008297:Male; D008550:Melatonin / Q000008:administration & dosage / Q000494:pharmacology*; D009043:Motor Activity / Q000187:drug effects*; D016627:Oxidopamine; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D017378:Quinolinic Acid; D011805:Quinolinic Acids; D051381:Rats; D011919:Rats, Inbred Strains
D006892:Hydroxydopamines; D011805:Quinolinic Acids; D016627:Oxidopamine; D017378:Quinolinic Acid; D008550:Melatonin; D001058:Apomorphine